Ben Butkus

MUNICH – Pathogen surveillance on a national scale based on anonymized metagenomic sequencing data from multiple labs is feasible and could be quickly mobilized to address disease outbreaks, according to a presentation at the European Society of Clinical Microbiology and Infectious Diseases global congress (ESCMID Global) this week.

MUNICH – Watchmaker Genomics, a company known more for its engineered enzymes for use in next-generation sequencing and cancer research applications, this week showcased its newer products for infectious disease molecular diagnostics developers here at the European Society of Clinical Microbiology and Infectious Diseases global congress (ESCMID Global).